Хайлтын үр дүнгүүд - Cinzia Aurilia
- 20-н 1 - 20 үр дүнгүүдийг харуулж байна
-
1
Dopaminergic symptoms in migraine -н Piero Barbanti, Luisa Fofi, Cinzia Aurilia, Gabriella Egeo
Хэвлэсэн 2013Revisão -
2
-
3
-
4
-
5
-
6
Oxidative Stress and Inflammation in Osteoporosis: Molecular Mechanisms Involved and the Relationship with microRNAs -н Teresa Iantomasi, Cecilia Romagnoli, Gaia Palmini, Simone Donati, Irene Falsetti, Francesca Miglietta, Cinzia Aurilia, Francesca Marini, Francesca Giusti, Maria Luisa Brandi
Хэвлэсэн 2023Revisão -
7
Impact of multiple treatment cycles with anti-CGRP monoclonal antibodies on migraine course: focus on discontinuation periods. Insights from the multicenter, prospective, I-GRAINE... -н Piero Barbanti, Cinzia Aurilia, Gabriella Egeo, Stefania Proietti, Paola Torelli, Florindo d’Onofrio, Antonio Carnevale, Sofia Tavani, Bianca Orlando, Giulia Fiorentini, Bruno Colombo, Massimo Filippi, Stefano Bonassi, Sabina Cevoli
Хэвлэсэн 2024Artigo -
8
Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study) -н Piero Barbanti, Gabriella Egeo, Cinzia Aurilia, Florindo d’Onofrio, Maria Albanese, Ilaria Cetta, Paola Di Fiore, Maurizio Zucco, Massimo Filippi, Francesco Bono, Claudia Altamura, Stefania Proietti, Stefano Bonassi, Fabrizio Vernieri
Хэвлэсэн 2022Artigo -
9
Very-low-calorie ketogenic diet vs hypocaloric balanced diet in the prevention of high-frequency episodic migraine: the EMIKETO randomized, controlled trial -н Massimiliano Caprio, Eleonora Moriconi, Elisabetta Camajani, Alessandra Feraco, Vincenzo Marzolla, Laura Vitiello, Stefania Proietti, Andrea Armani, Stefania Gorini, Caterina Mammi, Gabriella Egeo, Cinzia Aurilia, Giulia Fiorentini, Carlo Tomino, Piero Barbanti
Хэвлэсэн 2023Artigo -
10
Three-year treatment with anti-CGRP monoclonal antibodies modifies migraine course: the prospective, multicenter I-GRAINE study -н Piero Barbanti, Cinzia Aurilia, Paola Torelli, Gabriella Egeo, Florindo d’Onofrio, Cinzia Finocchi, Antonio Carnevale, Giovanna Viticchi, Marco Russo, Simone Quintana, Bianca Orlando, Giulia Fiorentini, Roberta Messina, Marco Bartolini, Francesca Pistoia, Massimo Filippi, Stefano Bonassi, Sabina Cevoli, Alice Mannocci
Хэвлэсэн 2025Artigo -
11
Maintenance of response and predictive factors of 1‐year <scp>GalcanezumAb</scp> treatment in real‐life migraine patients in <scp>Italy</scp>: The multicenter prospective cohort <s... -н Fabrizio Vernieri, Nicoletta Brunelli, Marilena Marcosano, Cinzia Aurilia, Gabriella Egeo, Carlo Lovati, Valentina Favoni, Armando Perrotta, Ilaria Maestrini, Renata Rao, Luigi d’Onofrio, Cinzia Finocchi, Marco Aguggia, Francesco Bono, Angelo Ranieri, Maria Albanese, Vittorio Di Piero, Sabina Cevoli, Claudia Altamura, Piero Barbanti
Хэвлэсэн 2022Artigo -
12
Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study) -н Fabrizio Vernieri, Claudia Altamura, Nicoletta Brunelli, Carmelina Maria Costa, Cinzia Aurilia, Gabriella Egeo, Luisa Fofi, Valentina Favoni, Giulia Pierangeli, Carlo Lovati, Marco Aguggia, Florindo d’Onofrio, Alberto Doretti, Paola Di Fiore, Cinzia Finocchi, Renata Rao, Francesco Bono, Angelo Ranieri, Maria Albanese, Sabina Cevoli, Piero Barbanti
Хэвлэсэн 2021Artigo -
13
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients -н Piero Barbanti, Gabriella Egeo, Cinzia Aurilia, Claudia Altamura, Florindo d’Onofrio, Cinzia Finocchi, Maria Albanese, Marco Aguggia, Renata Rao, Maurizio Zucco, Fabio Frediani, Massimo Filippi, Roberta Messina, Sabina Cevoli, Antonio Carnevale, Giulia Fiorentini, Stefano Messina, Francesco Bono, Paola Torelli, Stefania Proietti, Stefano Bonassi, Fabrizio Vernieri
Хэвлэсэн 2022Artigo -
14
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study -н Piero Barbanti, Cinzia Aurilia, Gabriella Egeo, Stefania Proietti, Florindo d’Onofrio, Paola Torelli, Marco Aguggia, Davide Bertuzzo, Cinzia Finocchi, Michele Trimboli, Sabina Cevoli, Giulia Fiorentini, Bianca Orlando, Maurizio Zucco, Laura Di Clemente, Ilaria Cetta, Bruno Colombo, Monica Laura Bandettini di Poggio, Valentina Favoni, Licia Grazzi, Antonio Salerno, Antonio Carnevale, Micaela Robotti, Fabio Frediani, Claudia Altamura, Massimo Filippi, Fabrizio Vernieri, Stefano Bonassi
Хэвлэсэн 2024Artigo -
15
Late Response to Anti-CGRP Monoclonal Antibodies in Migraine -н Piero Barbanti, Cinzia Aurilia, Gabriella Egeo, Paola Torelli, Stefania Proietti, Sabina Cevoli, Stefano Bonassi, Giulia Fiorentini Psy, Roberta Messina, Bruno Colombo, Florindo d’Onofrio, Maria Albanese, Cinzia Finocchi, Antonio Salerno, B. Mercuri, Antonio Carnevale, Francesco Bono, Fabio Frediani, Licia Grazzi, Domenico D’Amico, Massimo Filippi, Claudia Altamura, Fabrizio Vernieri, Marco Aguggia, Davide Bertuzzo, Maurizio Zucco, Laura Di Clemente, Michele Trimboli, Valentina Favoni, Paola Di Fiore
Хэвлэсэн 2023Artigo -
16
Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study -н Piero Barbanti, Gabriella Egeo, Stefania Proietti, Florindo d’Onofrio, Cinzia Aurilia, Cinzia Finocchi, Laura Di Clemente, Maurizio Zucco, Alberto Doretti, Stefano Messina, Massimo Autunno, Angelo Ranieri, Antonio Carnevale, Bruno Colombo, Massimo Filippi, Miriam Tasillo, Steno Rinalduzzi, Pietro Querzani, Giuliano Sette, Lorenzo Forino, Francesco Zoroddu, Micaela Robotti, Alessandro Valenza, Cecilia Camarda, L. Borrello, Marco Aguggia, Giovanna Viticchi, Carlo Tomino, Giulia Fiorentini, Bianca Orlando, Stefano Bonassi, Paola Torelli
Хэвлэсэн 2024Artigo -
17
Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experi... -н Claudia Altamura, Nicoletta Brunelli, Marilena Marcosano, Cinzia Aurilia, Gabriella Egeo, Carlo Lovati, Valentina Favoni, Armando Perrotta, Ilaria Maestrini, Francesca Schiano di Cola, Florindo d’Onofrio, Cinzia Finocchi, Davide Bertuzzo, Francesco Bono, Angelo Ranieri, Maria Albanese, Roberta Messina, Alberto Doretti, Vittorio Di Piero, Sabina Cevoli, Piero Barbanti, Fabrizio Vernieri, Carmelina Maria Costa, Luisa Fofi, Renata Rao, Luigi d’Onofrio, Daniele Spitalieri, Marco Aguggia, Fabio Bombardieri, Bruno Colombo, Massimo Filippi, Stefano Messina, Gianluca Demirtzidis
Хэвлэсэн 2022Artigo -
18
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study -н Raffaele Ornello, Carlo Baraldi, Simona Guerzoni, Giorgio Lambru, Anna P. Andreou, Bianca Raffaelli, Astrid Gendolla, Piero Barbanti, Cinzia Aurilia, Gabriella Egeo, Sabina Cevoli, Valentina Favoni, Fabrizio Vernieri, Claudia Altamura, Antonio Russo, Marcello Silvestro, Elisabetta Dalla Valle, Andrea Mancioli, Angelo Ranieri, Gennaro Alfieri, Н. В. Латышева, E. G. Filatova, Jamie Talbot, Shuli Cheng, Dagny Holle, Armin Scheffler, Tomáš Nežádal, Dana Čtrnáctá, Jitka Šípková, Zuzana Matoušová, Alfonsina Casalena, Maurizio Maddestra, Stefano Viola, Giannapia Affaitati, Maria Adele Giamberardino, Francesca Pistoia, Uwe Reuter, Simona Sacco
Хэвлэсэн 2022Artigo -
19
Early and sustained efficacy of fremanezumab over 24-weeks in migraine patients with multiple preventive treatment failures: the multicenter, prospective, real-life FRIEND2 study -н Piero Barbanti, Gabriella Egeo, Cinzia Aurilia, Paola Torelli, Cinzia Finocchi, Florindo d’Onofrio, Luigi d’Onofrio, Renata Rao, Stefano Messina, Laura Di Clemente, Angelo Ranieri, Massimo Autunno, Giuliano Sette, Bruno Colombo, Antonio Carnevale, Marco Aguggia, Miriam Tasillo, Francesco Zoroddu, Fabio Frediani, Massimo Filippi, Carlo Tomino, Stefania Proietti, Stefano Bonassi, Maria Albanese, Marco Bertolini, Davide Bertuzzo, Maria Bloise, Francesco Bono, L. Borrello, Cecilia Camarda, Giulia Fiorentini, Licia Grazzi, Domenica Le Pera, Roberta Messina, Pietro Querzani, Antonio Salerno, Silvia Strumia, Alessandro Valenza, Fabrizio Vernieri, Giovanna Viticchi
Хэвлэсэн 2023Artigo -
20
Noninvasive vagus nerve stimulation as acute therapy for migraine -н Cristina Tassorelli, Licia Grazzi, Marina de Tommaso, Giulia Pierangeli, Paolo Martelletti, Innocenzo Rainero, Stefanie Dorlas, Pierangelo Geppetti, Anna Ambrosini, Paola Sarchielli, Eric Liebler, Piero Barbanti, Cristina Tassorelli, Vito Bitetto, Roberto De Icco, Daniele Martinelli, Grazia Sances, Monica Bianchi, Licia Grazzi, Anna Maria Padovan, Marina de Tommaso, Katia Ricci, Eleonora Vecchio, Pietro Cortelli, Sabina Cevoli, Giulia Pierangeli, Rossana Terlizzi, Paolo Martelletti, Andrea Negro, Gabriella Addolorata Chiariello, Innocenzo Rainero, Paola Martino, Annalisa Gai, Flora Govone, Federica Masuzzo, Elisa Rubino, Maria Claudia Torrieri, Alessandro Vacca, Pierangelo Geppetti, Alberto Chiarugi, Francesco De Cesaris, Simone Li Puma, Chiara Lupi, Ilaria M. Marone, Anna Ambrosini, Armando Perrotta, Paola Sarchielli, Laura Bernetti, Ilenia Corbelli, Michele Romoli, Simone Simoni, Angela Verzina, Piero Barbanti, Cinzia Aurilia, Gabriella Egeo, Luisa Fofi, Eric Liebler, Annelie Andersson, Lia Spitzer, Juana Marin, Candace K. McClure, Lisa Thackerey, Maria Giovanna Baldi, Daniela Di Maro
Хэвлэсэн 2018Artigo
Хайх хэрэгслүүд:
Холбогдох сэдвүүд
Medicine
Internal medicine
Migraine
Chronic Migraine
Adverse effect
Psychiatry
Tolerability
Biology
Clinical endpoint
Neurology
Randomized controlled trial
Calcitonin gene-related peptide
Endocrinology
Neuropeptide
Prospective cohort study
Receptor
Anesthesia
Clinical trial
Cohort
Immunology
Antibody
Bioinformatics
Monoclonal antibody
Neuroradiology
Pediatrics
Body mass index
Bone resorption
Calcitonin
Cohort study
Discontinuation